BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 16, 2006
View Archived Issues
Nalmefene shows promise in treating pathological gambling / News in Context
Read More
NXY-059 appears to reduce disability in ischemic stroke patients
Read More
LRH-1 activation: Potential efficacy as a treatment for atherosclerosis
Read More
New localized radiotherapeutic for prostate cancer
Read More
Capsaicin patch reduces pain in HIV-associated distal sensory polyneuropathy
Read More
GCPII inhibitor targeted for neuroprotection and prostate cancer
Read More
Neurochem completes rolling NDA for Fibrillex in AA amyloidosis
Read More
Phase I study of lemuteporfin in BPH fails to meet primary efficacy objective
Read More
Santen updates status of ophthalmic programs
Read More
ProMetic BioSciences cleared for Canadian phase Ib/II study of PBI-1402
Read More
Ranbaxy and CIH establish joint venture for antiretrovirals in South Africa
Read More
Eltrombopag begins phase III trials for ITP
Read More
Avant's typhoid fever vaccine Ty-800 studied in new phase I/II trial
Read More
BioXell and Lay Line Genomics sign agreement for MNAC13
Read More
European COMP recommends orphan drug designation for 1D09C3
Read More
Orthokine approved in E.U.
Read More
Glenmark discovers new drug targeting obesity
Read More
Retapamulin NDA under FDA review
Read More
Pfizer looks to value drivers to grow business
Read More
Prophylactic and therapeutic efficacy of targeting TLR9 for HSV-2
Read More
Recent Incyte patent describes new therapeutic agents for HIV infection
Read More
New agents for endocrine-related disorders imparted in recent patent literature
Read More
Orphan drug designation for TRX-4 in type 1 diabetes
Read More
Phase Ib trial investigates AP-23573 plus doxorubicin for cancer
Read More
MB-07803 studied in phase I for type 2 diabetes
Read More
New therapeutic agents described for cardiovascular disorders
Read More
Japanese phase II trial for gaboxadol
Read More
Ambrisentan use in PAH patients who discontinue other ERA therapy
Read More
